Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Features

Funding the Future: How Industry Support for CV Trials Could Evolve

Michael O'Riordan

December 17, 2020

News Conference News AHA 2020

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Michael O'Riordan

November 19, 2020

News Conference News AHA 2020

SCAPIS: CTA Finds Silent CAD in 42% of Middle-aged Adults

Shelley Wood

November 13, 2020

News Daily News

COVID-19: TCTMD’s Daily Dispatch for October

Todd Neale

October 01, 2020

News Daily News

Open Letter Calls on CV Societies to Discourage CMR After Mild COVID-19

Shelley Wood

September 15, 2020

News Daily News

COVID-19: TCTMD’s Daily Dispatch for September

Todd Neale

September 01, 2020

News Daily News

CABG Loses Survival Advantage in Women at 10 Years: SYNTAXES

Yael L. Maxwell

August 20, 2020

News Daily News

Don’t Mistake Microthrombi for Myocarditis in COVID-19 STEMI, Case Report Warns

Caitlin E. Cox

July 22, 2020

News Daily News

Black Patients in RCTs of PCI Show Worse Long-term Outcomes

Caitlin E. Cox

July 10, 2020

News Daily News

Dexamethasone Cuts Death by One-Third in Ventilated COVID-19 Patients

Michael O'Riordan

June 16, 2020

News Daily News

Case by Case, a Portrait Emerges of COVID-19’s Cardiovascular Fingerprint

Caitlin E. Cox

June 15, 2020

News Features

Cardiology After COVID-19: Physicians Predict Lasting Change

Yael L. Maxwell

May 20, 2020

News

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

Michael O'Riordan

April 17, 2020

News Daily News

Inclisiran Data in NEJM Prompt Talk of What Comes Next

Caitlin E. Cox

March 24, 2020

News Features

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

Michael O'Riordan

March 03, 2020

News Daily News

BBC Makes New EXCEL Allegations, Says Investigators Ignored Safety Concerns

Michael O'Riordan

February 21, 2020

News Daily News

Earlier, Longer Interventions Proposed for Optimal Population LDL Cholesterol

Yael L. Maxwell

January 28, 2020

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

Advertisement

Funding the Future: How Industry Support for CV Trials Could Evolve

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

SCAPIS: CTA Finds Silent CAD in 42% of Middle-aged Adults

COVID-19: TCTMD’s Daily Dispatch for October

Open Letter Calls on CV Societies to Discourage CMR After Mild COVID-19

COVID-19: TCTMD’s Daily Dispatch for September

CABG Loses Survival Advantage in Women at 10 Years: SYNTAXES

Don’t Mistake Microthrombi for Myocarditis in COVID-19 STEMI, Case Report Warns

Black Patients in RCTs of PCI Show Worse Long-term Outcomes

Dexamethasone Cuts Death by One-Third in Ventilated COVID-19 Patients

Case by Case, a Portrait Emerges of COVID-19’s Cardiovascular Fingerprint

Cardiology After COVID-19: Physicians Predict Lasting Change

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

Inclisiran Data in NEJM Prompt Talk of What Comes Next

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

BBC Makes New EXCEL Allegations, Says Investigators Ignored Safety Concerns

Earlier, Longer Interventions Proposed for Optimal Population LDL Cholesterol

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content